Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPA + Dexamethasone + CMT in Relapsed/Refractory AML
NCT01009931Phase 2Terminated
- Sponsor
- Rutgers University
- Start
- Mar 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 12-o-tetradecanoylphorbol-13-acetate in acute myeloid leukemia (AML), sponsored by Rutgers University. Started Mar 2011; status: terminated.
02
Drugs
12-o-tetradecanoylphorbol-13-acetate
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01009931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009931.